Conference Proceedings

Maintenance of response through up to 3-years of continuous guselkumab treatment of psoriasis in the VOYAGE 2 phase 3 trial

Kristian Reich, Michael Song, Bruce Randazzo, Shu Li, Yaung-Kaung Shen, Chenglong Han, April Armstrong, Peter Foley, Kenneth B Gordon

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | MOSBY-ELSEVIER | Published : 2019

Grants

Funding Acknowledgements

Supported 100% by Janssen Research & Development.